Drug Type Gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism CD46 modulators(Membrane cofactor protein modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thalassemia | Preclinical | Greece | 01 May 2018 |